Remove Biobanking Remove Containment Remove RNA
article thumbnail

Alnylam finds belly fat gene and drug target in UK Biobank study

pharmaphorum

The RNA interference specialist says its researchers and collaborators have identified mutations in a gene called INHBE that are associated with protection against abdominal obesity and metabolic syndrome – a condition impacting more than 20% of adults worldwide. . Image by Bruno /Germany from Pixabay .

article thumbnail

CENTOGENE Opens Walk-In COVID-19 Testing Facility at Berlin Brandenburg Airport

The Pharma Data

CENTOGENE’s SARS-CoV-2 test is a molecular diagnostic test performed for the in vitro qualitative detection of RNA from the SARS-CoV-2 in oropharyngeal samples from presymptomatic patients and probands according to the recommended testing by public health authority guidelines. A Complete Testing Solution. Important Notice and Disclaimer.